XJPX
7932
Market cap237mUSD
Dec 05, Last price
12,850.00JPY
1D
-0.54%
1Q
7.80%
Jan 2017
210.76%
Name
Nippi Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nippi,Incorporated, together with its subsidiaries, manufactures and sells collagen casings, gelatin and collagen peptides, cosmetics and functional foods, functional polymers, and life science products in Japan and internationally. The company offers collagen casings for use in various fields, including foods, medicines and pharmaceuticals, and cosmetics; gelatin, which is used in food products, pharmaceutical products, photo films, etc.; and leather products for the automotive industry. It also develops cosmetics and functional foods with collagen; offers Nippi Linker, a vinyl chloride resin, which is primarily used for electric wires and masking films; and provides Nippi V Foam, a foam made of vinyl chloride for welder processing that is used in cars, quilt products, and novelty goods. In addition, the company engages in real estate leasing activities; and provides life science products that include laminin, lab equipment and supplies, and reagents, as well as contract services and bovine spongiform encephalopathy test kits. The company was formerly known as The Japan Leather Mfg. Co., Ltd. and changed its name to Nippi,Incorporated in February 1974. Nippi,Incorporated was founded in 1907 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||